appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Akums Drugs and Pharmaceuticals Ltd
AKUMS
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Price
Price Upside
—
Earnings
Earnings Growth
—
Revenue
Rev. Growth
—
Company Profile
Akums Drugs and Pharmaceuticals is pharmaceutical contract development and manufacturing company.
Investor PresentationView older
View Older PresentationsPeersCompare with peers
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Shareholders meeting
Updates
Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Submission of additional details as per SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July 2023 '. for Our disclosure dated 19th November, 24 on Execution of Exclusive Master Sales Agreement with Caregen Co., Ltd | Download
Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Submission of additional details as per SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13th July 2023 '. for Our disclosure dated 19th November, 24 on Execution of Exclusive Master Sales Agreement with Caregen Co., Ltd | Download
Updates
Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Akums exclusively ties up with Jagdale for marketing of Ready-to-Drink nutritional beverages in aseptic carton technology '. | Download
Akums Drugs and Pharmaceuticals Limited has informed the Exchange regarding 'Akums exclusively ties up with Jagdale for marketing of Ready-to-Drink nutritional beverages in aseptic carton technology '. | Download
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant